Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
August-2015 Volume 12 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
August-2015 Volume 12 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Effect of cell cycle phase on the sensitivity of SAS cells to sonodynamic therapy using low‑intensity ultrasound combined with 5‑aminolevulinic acid in vitro

  • Authors:
    • Nan Li
    • Miao Sun
    • Yao Wang
    • Yanhong Lv
    • Zheng Hu
    • Wenwu Cao
    • Jinhua Zheng
    • Xiaohui Jiao
  • View Affiliations / Copyright

    Affiliations: Department of Oral Maxillofacial Surgery, School of Stomatology, Harbin Medical University, Harbin, Heilongjiang 150001, P.R. China, Department of Stomatology, the Fourth Clinical College, Harbin Medical University, Harbin, Heilongjiang 150001, P.R. China, Department of Anatomy, Basic Medical Science College, Harbin Medical University, Harbin, Heilongjiang 150081, P.R. China, Laboratory of Sono‑ and Photo‑theranostic Technologies, Harbin Institute of Technology, Harbin, Heilongjiang 150080, P.R. China
  • Pages: 3177-3183
    |
    Published online on: May 7, 2015
       https://doi.org/10.3892/mmr.2015.3747
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Sonodynamic therapy (SDT) with 5‑aminolevulinic acid (5‑ALA) can effectively inhibit various types of tumor in vitro and in vivo. However, the association between the efficacy of SDT and the phase of the cell cycle remains to be elucidated. 5‑ALA may generate different quantities of sonosensitizer, protoporphyrin IX (PpIX), in different phases of the cell cycle, which may result in differences in sensitivity to 5‑ALA‑induced SDT. The present study aimed to investigate the effect of the cell cycle on the susceptibility of SAS cells to SDT following synchronization to different cell cycle phases. These results indicates that the rates of cell death and apoptosis of the SAS cells in the S and G2/M phases were significantly higher following SDT, compared with those in the G1‑phase cells and unsynchronized cells, with a corresponding increase in PpIX in the S and G2/M cells. In addition, the expression of caspase‑3 increased, while that of B‑cell lymphoma (Bcl)‑2 decreased markedly in theS and G2/M cells following SDT. Cyclin A was also expressed at higher levels in the S and G2/M cells, compared with the G1‑phase cells. SDT also caused a significant upregulation of cyclin A in all phases of the cell cycle, however this was most marked in the S and G2/M cells. It was hypothesized that high expression levels of cyclin A in the S and G2/M cells may promote the induction of caspase‑3 and reduce the induction of Bcl‑2 by SDT and, therefore, enhance apoptosis. Taken together, these data demonstrated that cells in The S and G2/M phases generate more intracellular PpIX, have higher levels of cyclin A and are, therefore, more sensitive to SDT‑induced cytotoxicity. These findings indicate the potential novel approach to preventing the onset of cancer by combining cell‑cycle regulators with SDT. This sequential combination therapy may be a simple and cost‑effective way of enhancing the effects of SDT in clinical settings.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1 

Shibaguchi H, Tsuru H and Kuroki M: Sonodynamic cancer therapy: a non-invasive and repeatable approach using low-intensity ultrasound with a sonosensitizer. Anticancer Res. 31:2425–2429. 2011.PubMed/NCBI

2 

Rosenthal I, Sostaric JZ and Riesz P: Sonodynamic therapy-a review of the synergistic effects of drugs and ultrasound. Ultrason Sonochem. 11:349–363. 2004.PubMed/NCBI

3 

Tsuru H, Shibaguchi H, Kuroki M and Yamashita Y: Tumor growth inhibition by sonodynamic therapy using a novel sonosensitizer. Free Radic Biol Med. 53:464–472. 2012. View Article : Google Scholar : PubMed/NCBI

4 

Yumita N, Okuyama N, Sasaki K and Umemura S: Sonodynamic therapy on chemically induced mammary tumor: pharmacokinetics, tissue distribution and sonody-namically induced antitumor effect of gallium-porphyrin complex ATX-70. Cancer Chemother Pharmacol. 60:891–897. 2007. View Article : Google Scholar : PubMed/NCBI

5 

Komori C, Okada K, Kawamura K, Chida S and Suzuki T: The sonodynamic antitumor effect of methylene blue on sarcoma180 cells in vitro. Anticancer Res. 29:2411–2415. 2009.PubMed/NCBI

6 

Liu Q, Li X, Xiao L, Wang P, Wang X and Tang W: Sonodynamically induced antitumor effect of hematoporphyrin on Hepatoma 22. Ultrason Sonochem. 15:943–948. 2008. View Article : Google Scholar : PubMed/NCBI

7 

Ohmura T, Fukushima T, Shibaguchi H, et al: Sonodynamic therapy with 5-aminolevulinic acid and focused ultrasound for deep-seated intracranial glioma in rat. Anticancer Res. 31:2527–2533. 2011.PubMed/NCBI

8 

Peng Q, Berg K, Moan J, Kongshaug M and Nesland JM: 5-Aminolevulinic acid-based photodynamic therapy: principles and experimental research. Photochem Photobiol. 65:235–251. 1997. View Article : Google Scholar : PubMed/NCBI

9 

Zenzen V and Zankl H: Protoporphyrin IX-accumulation in human tumor cells following topical ALA- and h-ALA-application in vivo. Cancer Lett. 202:35–42. 2003. View Article : Google Scholar : PubMed/NCBI

10 

Wu SM, Ren QG, Zhou MO, Peng Q and Chen JY: Protoporphyrin IX production and its photodynamic effects on glioma cells, neuroblastoma cells and normal cerebellar granule cells in vitro with 5-aminolevulinic acid and its hexylester. Cancer Lett. 200:123–131. 2003. View Article : Google Scholar : PubMed/NCBI

11 

Schick E, Kaufmann R, Ruck A, Hainzl A and Boehncke WH: Influence of activation and differentiation of cells on the effectiveness of photodynamic therapy. Acta Derm Venereol. 75:276–279. 1995.PubMed/NCBI

12 

Wyld L, Burn JL, Reed MW and Brown NJ: Factors affecting aminolaevulinic acid-induced generation of protoporphyrin IX. Br J Cancer. 76:705–712. 1997. View Article : Google Scholar : PubMed/NCBI

13 

Wyld L, Smith O, Lawry J, Reed MW and Brown NJ: Cell cycle phase influences tumour cell sensitivity to aminolaevulinic acid-induced photodynamic therapy in vitro. Br J Cancer. 78:50–55. 1998. View Article : Google Scholar : PubMed/NCBI

14 

Sano M, Furuta T, Takahira K, et al: Cell-cycle-dependent efficacy of photodynamic therapy with ATX-S10(Na). Lasers Med Sci. 20:1–5. 2005. View Article : Google Scholar : PubMed/NCBI

15 

Heinemann L, Simpson GR, Annels NE, et al: The effect of cell cycle synchronization on tumor sensitivity to reovirus oncolysis. Mol Ther. 18:2085–2093. 2010. View Article : Google Scholar : PubMed/NCBI

16 

Huang X, Di Liberto M, Jayabalan D, et al: Prolonged early G(1) arrest by selective CDK4/CDK6 inhibition sensitizes myeloma cells to cytotoxic killing through cell cycle-coupled loss of IRF4. Blood. 120:1095–1106. 2012. View Article : Google Scholar : PubMed/NCBI

17 

Hassan MAIA, Braam SR and Kruyt FAE: Paclitaxel and vincristine potentiate adenoviral oncolysis that is associated with cell cycle and apoptosis modulation, whereas they differentially affect the viral life cycle in non-small-cell lung cancer cells. Cancer Gene Ther. 13:1105–1114. 2006. View Article : Google Scholar

18 

Connell CM, Wheatley SP and McNeish IA: Nuclear survivin abrogates multiple cell cycle checkpoints and enhances viral oncolysis. Cancer Res. 68:7923–7931. 2008. View Article : Google Scholar : PubMed/NCBI

19 

Lv Y, Fang M, Zheng J, et al: Low-intensity ultrasound combined with 5-aminolevulinic acid administration in the treatment of human tongue squamous carcinoma. Cell Physiol Biochem. 30:321–333. 2012. View Article : Google Scholar : PubMed/NCBI

20 

Song W, Cui H, Zhang R, Zheng J and Cao W: Apoptosis of SAS cells induced by sonodynamic therapy using 5-aminolevulinic acid sonosensitizer. Anticancer Res. 31:39–45. 2011.PubMed/NCBI

21 

Khammanit R, Chantakru S, Kitiyanant Y and Saikhun J: Effect of serum starvation and chemical inhibitors on cell cycle synchronization of canine dermal fibroblasts. Theriogenology. 70:27–34. 2008. View Article : Google Scholar : PubMed/NCBI

22 

Banfalvi G: Overview of cell synchronization. Methods Mol Biol. 761:1–23. 2011.PubMed/NCBI

23 

Gao Z, Zheng J, Yang B, et al: Sonodynamic therapy inhibits angiogenesis and tumor growth in a xenograft mouse model. Cancer Lett. 335:93–99. 2013. View Article : Google Scholar : PubMed/NCBI

24 

Vokes EE: The promise of biochemical modulation in combined modality therapy. Semin Oncol. 21:29–33. 1994.PubMed/NCBI

25 

Humphrey RM and Dewey WC: Radiosensitivity of normal and 5-bromodeoxyuridine treated mammalian cells during different phases of the cell cycle. Exp Cell Res. 39:483–495. 1965. View Article : Google Scholar : PubMed/NCBI

26 

Ma LW, Moan J, Steen HB and Iani V: Anti-tumour activity of photodynamic therapy in combination with mitomycin C in nude mice with human colon adenocarcinoma. Br J Cancer. 71:950–956. 1995. View Article : Google Scholar : PubMed/NCBI

27 

Shibata Y, Matsumura A, Yoshida F, et al: Cell cycle dependency of porphyrin uptake in a glioma cell line. Cancer Lett. 129:77–85. 1998. View Article : Google Scholar : PubMed/NCBI

28 

Terasima T and Tolmach LJ: Variations in several responses of HeLa cells to x-irradiation during the division cycle. Biophys J. 3:11–33. 1963. View Article : Google Scholar : PubMed/NCBI

29 

Meikrantz W and Schlegel R: Apoptosis and the cell cycle. J Cell Biochem. 58:160–174. 1995. View Article : Google Scholar : PubMed/NCBI

30 

Yam CH, Fung TK and Poon RYC: Cyclin A in cell cycle control and cancer. Cell Mol Life Sci. 59:1317–1326. 2002. View Article : Google Scholar : PubMed/NCBI

31 

Pagano M, Pepperkok R, Verde F, Ansorge W and Draetta G: Cyclin A is required at two points in the human cell cycle. EMBO J. 11:961–971. 1992.PubMed/NCBI

32 

Wang SJ, Hasham MG, Isordia-Salas I, Tsygankov AY, Colman RW and Guo YL: Regulation of cardiovascular signaling by kinins and products of similar converting enzyme systems - Upregulation of Cdc2 and cyclin A during apoptosis of endothelial cells induced by cleaved high-molecular-weight kininogen. Am J Physiol Heart Circ Physiol. 284:H1917–H1923. 2003. View Article : Google Scholar : PubMed/NCBI

33 

Meikrantz W and Schlegel R: Suppression of apoptosis by dominant negative mutants of cyclin-dependent protein kinases. J Biol Chem. 271:10205–10209. 1996. View Article : Google Scholar : PubMed/NCBI

34 

Meikrantz W, Gisselbrecht S, Tam SW and Schlegel R: Activation of Cyclin a-Dependent Protein-Kinases during Apoptosis. Proc Natl Acad Sci USA. 91:3754–3758. 1994. View Article : Google Scholar

35 

Wang XH, Song YJ, Ren JS and Qu XG: Knocking-Down Cyclin A(2) by siRNA Suppresses Apoptosis and Switches Differentiation Pathways in K562 Cells upon Administration with Doxorubicin. PLoS One. 4:e66652009. View Article : Google Scholar : PubMed/NCBI

36 

Ekberg J and Persson J: Post-translational modification of cyclin A1 is associated with staurosporine and TNF alpha induced apoptosis in leukemic cells. Mol Cell Biochem. 320:115–124. 2009. View Article : Google Scholar

37 

Hiromura K, Pippin JW, Blonski MJ, Roberts JM and Shankland SJ: The subcellular localization of cyclin dependent kinase 2 determines the fate of mesangial cells: role in apoptosis and proliferation. Oncogene. 21:1750–1758. 2002. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Li N, Sun M, Wang Y, Lv Y, Hu Z, Cao W, Zheng J and Jiao X: Effect of cell cycle phase on the sensitivity of SAS cells to sonodynamic therapy using low‑intensity ultrasound combined with 5‑aminolevulinic acid in vitro. Mol Med Rep 12: 3177-3183, 2015.
APA
Li, N., Sun, M., Wang, Y., Lv, Y., Hu, Z., Cao, W. ... Jiao, X. (2015). Effect of cell cycle phase on the sensitivity of SAS cells to sonodynamic therapy using low‑intensity ultrasound combined with 5‑aminolevulinic acid in vitro. Molecular Medicine Reports, 12, 3177-3183. https://doi.org/10.3892/mmr.2015.3747
MLA
Li, N., Sun, M., Wang, Y., Lv, Y., Hu, Z., Cao, W., Zheng, J., Jiao, X."Effect of cell cycle phase on the sensitivity of SAS cells to sonodynamic therapy using low‑intensity ultrasound combined with 5‑aminolevulinic acid in vitro". Molecular Medicine Reports 12.2 (2015): 3177-3183.
Chicago
Li, N., Sun, M., Wang, Y., Lv, Y., Hu, Z., Cao, W., Zheng, J., Jiao, X."Effect of cell cycle phase on the sensitivity of SAS cells to sonodynamic therapy using low‑intensity ultrasound combined with 5‑aminolevulinic acid in vitro". Molecular Medicine Reports 12, no. 2 (2015): 3177-3183. https://doi.org/10.3892/mmr.2015.3747
Copy and paste a formatted citation
x
Spandidos Publications style
Li N, Sun M, Wang Y, Lv Y, Hu Z, Cao W, Zheng J and Jiao X: Effect of cell cycle phase on the sensitivity of SAS cells to sonodynamic therapy using low‑intensity ultrasound combined with 5‑aminolevulinic acid in vitro. Mol Med Rep 12: 3177-3183, 2015.
APA
Li, N., Sun, M., Wang, Y., Lv, Y., Hu, Z., Cao, W. ... Jiao, X. (2015). Effect of cell cycle phase on the sensitivity of SAS cells to sonodynamic therapy using low‑intensity ultrasound combined with 5‑aminolevulinic acid in vitro. Molecular Medicine Reports, 12, 3177-3183. https://doi.org/10.3892/mmr.2015.3747
MLA
Li, N., Sun, M., Wang, Y., Lv, Y., Hu, Z., Cao, W., Zheng, J., Jiao, X."Effect of cell cycle phase on the sensitivity of SAS cells to sonodynamic therapy using low‑intensity ultrasound combined with 5‑aminolevulinic acid in vitro". Molecular Medicine Reports 12.2 (2015): 3177-3183.
Chicago
Li, N., Sun, M., Wang, Y., Lv, Y., Hu, Z., Cao, W., Zheng, J., Jiao, X."Effect of cell cycle phase on the sensitivity of SAS cells to sonodynamic therapy using low‑intensity ultrasound combined with 5‑aminolevulinic acid in vitro". Molecular Medicine Reports 12, no. 2 (2015): 3177-3183. https://doi.org/10.3892/mmr.2015.3747
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team